These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1386820)

  • 21. Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active site.
    Braestrup C; Andersen PH
    J Neurochem; 1987 Jun; 48(6):1667-72. PubMed ID: 2952762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic estradiol treatment increases ovariectomized rat striatal D-1 dopamine receptors.
    Lévesque D; Di Paolo T
    Life Sci; 1989; 45(19):1813-20. PubMed ID: 2531825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related changes in the turnover rates of D1-dopamine receptors in the retina and in distinct areas of the rat brain.
    Giorgi O; Pibiri MG; Dal Toso R; Ragatzu G
    Brain Res; 1992 Jan; 569(2):323-9. PubMed ID: 1347246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
    Bhargava HN; Gulati A
    J Pharmacol Exp Ther; 1990 Mar; 252(3):901-7. PubMed ID: 2138669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo.
    Andersen PH; Grønvald FC
    Life Sci; 1986 Apr; 38(16):1507-14. PubMed ID: 2871467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic methamphetamine treatment on the binding parameters of [3H]SCH 23390, a selective D1-dopamine receptor ligand, in the rat brain.
    Nonaka R; Moroji T
    Neurosci Lett; 1990 Nov; 120(1):109-12. PubMed ID: 2149876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Adv Exp Med Biol; 1986; 204():29-52. PubMed ID: 2878579
    [No Abstract]   [Full Text] [Related]  

  • 28. Ascorbic acid inhibits [3H]SCH-23390 binding to striatal dopamine D1 receptors.
    Wiener HL; Lajtha A; Sershen H
    J Recept Res; 1989; 9(4-5):331-9. PubMed ID: 2531799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoradiographic localization of dopamine DA1 receptors in rat kidney with [3H]Sch 23390.
    Huo T; Healy DP
    Am J Physiol; 1989 Sep; 257(3 Pt 2):F414-23. PubMed ID: 2528915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats.
    Bhargava HN; Gulati A; Ramarao P
    Pharmacology; 1991; 42(3):121-7. PubMed ID: 1647533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parallel decrease in the density of dopamine D1 and D2 receptors in corpus striatum of rats from 3 to 25 months of age.
    Hyttel J
    Pharmacol Toxicol; 1989 Jan; 64(1):55-7. PubMed ID: 2526948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep deprivation increases dopamine D1 receptor antagonist [3H]SCH 23390 binding and dopamine-stimulated adenylate cyclase in the rat limbic system.
    Demontis MG; Fadda P; Devoto P; Martellotta MC; Fratta W
    Neurosci Lett; 1990 Sep; 117(1-2):224-7. PubMed ID: 2149748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [3H]SCH 23390 identifies D-1 binding sites in rat striatum and other brain areas.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Pharm Pharmacol; 1986 Dec; 38(12):907-12. PubMed ID: 2880965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The distribution of dopamine D1 and D2 receptors in the brain of rodents and carnivores].
    Avgustinovich DF; Nikulina EM
    Zh Evol Biokhim Fiziol; 1992; 28(1):3-8. PubMed ID: 1387995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olfactory deprivation increases dopamine D2 receptor density in the rat olfactory bulb.
    Guthrie KM; Pullara JM; Marshall JF; Leon M
    Synapse; 1991 May; 8(1):61-70. PubMed ID: 1831300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postnatal development of dopamine D1 and D2 receptor sites in rat striatum.
    Gelbard HA; Teicher MH; Faedda G; Baldessarini RJ
    Brain Res Dev Brain Res; 1989 Sep; 49(1):123-30. PubMed ID: 2529061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lasting increase in D1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic methamphetamine administration.
    Ujike H; Akiyama K; Nishikawa H; Onoue T; Otsuki S
    Brain Res; 1991 Feb; 540(1-2):159-63. PubMed ID: 1829015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bidirectional changes in striatal D1-dopamine receptor density during chronic ethanol intake.
    Hamdi A; Prasad C
    Life Sci; 1993; 52(3):251-7. PubMed ID: 8423708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of dopamine D1 receptors in rat cortical areas, neostriatum, olfactory bulb and hippocampus in relation to endogenous dopamine contents.
    Diop L; Gottberg E; Brière R; Grondin L; Reader TA
    Synapse; 1988; 2(4):395-405. PubMed ID: 2973141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.